- $70.83m
- $97.64m
- $17.37m
- 60
- 47
- 34
- 44
Annual income statement for CNB, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 10.9 | 11.2 | 13.3 | 13.9 | 14.7 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 9.72 | 11.5 | 13.3 | 13.9 | 14.7 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 3.43 | 3.67 | 4.57 | 4.35 | 3.93 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.81 | 3 | 3.71 | 3.54 | 3.21 |
Net Income Before Extraordinary Items | |||||
Net Income | 2.81 | 3 | 3.71 | 3.54 | 3.21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.81 | 3 | 3.71 | 3.54 | 3.21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.32 | 2.48 | 3.07 | 2.92 | 2.65 |
Dividends per Share |